BioCentury
ARTICLE | Company News

Quest Group, Vitae deal

May 21, 2007 7:00 AM UTC

Vitae granted QSTG exclusive rights to three undisclosed pharmaceutical programs that include retinoic acid receptor and rexinoid receptor agonists and antagonists, as well as related molecules. QSTG...